A Registry for People With Lung Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMemorial Sloan Kettering Cancer Center
About this trial
Participants will complete questionnaires before surgery, between 2 to 4 weeks after surgery, and 6 months after surgery.
Eligibility criteria
Qualifiers
Age ≥18 years
Clinical Stage I with suspected NSCLC, classified preoperatively based on the AJCC TNM staging manual, 9th edition o Note: Tissue diagnosis of NSCLC is not required before enrollment. A pathologic diagnosis of NSCLC may be confirmed preoperatively with biopsy, intraoperatively with frozen section, or postoperatively on final pathology
Disqualifiers
Actively receiving lung cancer treatment or a history of lung cancer in the previous 5 years
History of chemotherapy or radiation therapy for a previous lung cancer
Synchronous secondary cancer in the lung or elsewhere in the body at the time of surgery
Carcinoid tumors
Trial design
Treatments tested in this trial
- Patient-Reported Outcomes Measurement Information System
Treatment groups
600 Participants
are divided into 1 treatment groupLocations
17Canada
University Health Network (Data Collection Only)M5G 2C4, TorontoOntario, Canada
Centre Hospitalier de l'Université de Montreal (Data Collection Only)H2L 4M1, MontrealQuebec, Canada
United States
Arizona
University of Arizona (Data Collection Only)85704, Tucson United States
Illinois
Rush University Medical Center (Data collection only)606012, Chicago United States
Sponsors and collaborators
Memorial Sloan Kettering Cancer Center
Lead sponsor
Source ClinicalTrials.gov